Biognosys

Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision making. It describes itself as the world leader in next-generation proteomics contract research services to support pharma and biotech research and clinical development, delivering these services from its laboratories in Boston and Zurich. Its offerings include discovery and targeted proteomics services, software such as Spectronaut for DIA proteomics, SpectroDive for targeted proteomics, SpectroMine for DDA proteomics, and the free QC tool QuiC, as well as peptide kits and reagents including PQ500 Reference Peptides for plasma proteomics quantification, the iRT kit for quality control, and sample preparation kits.

Biognosys is a company based in Schlieren, Switzerland. It invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision making. It delivers industry-leading proteomics contract research services from its laboratories in Boston and Zurich, and describes itself as a pioneer of Data-Independent Acquisition (DIA) and targeted proteomics. Its software solutions for proteomics include Spectronaut for DIA proteomics, SpectroDive for Targeted Proteomics, SpectroMine for DDA proteomics, and the free-of-charge QC tool QuiC. Its peptide kits and reagents include PQ500 Reference Peptides for plasma proteomics quantification, the iRT kit for quality control, and sample preparation kits. It has announced plans to launch metabolomics/lipidomics services for multiomics drug discovery and clinical research.

World leader in next-generation proteomics contract research services to support pharma and biotech research and clinical development.

• Spectronaut

  Software for DIA proteomics.

• SpectroDive

  Software for targeted proteomics.

• SpectroMine

  Software for DDA proteomics.

• QuiC

  Free-of-charge QC tool.

• PQ500 Reference Peptides

  Reference peptides for plasma proteomics quantification.

• iRT kit

  Kit for quality control.

• 2022.03.03

  Reported2022.03.03

  Biognosys launches expanded proteomics platform suite[6]Biognosys 推出扩展版蛋白质组学平台组合finanznachrichten.de

  Biognosys announced the launch of an expanded suite of proteomics platforms—TrueDiscovery, TrueTarget, and TrueSignature—for pharmaceutical and diagnostics customers across the R&D pipeline.

• 2019.12.02

  Reported2019.12.02

  Indivumed and Biognosys announce strategic partnership[7]Indivumed与Biognosys宣布战略合作prnewswire.com

  Indivumed announced a partnership with Biognosys to add proteome-level data from thousands of samples to the IndivuType multi-omics cancer database using Biognosys' proteomics technology.

Read more

1. 1Global Proteomics | Next-Generation Proteomics | Proteomic Solutionsbiognosys.com
2. 2Overview - Proteomics CRO - Biognosys Groupbiognosysgroup.com
3. 3Proteome | Protein Structure | Protein Functionbiognosys.com
4. 4Resources Archive - Biognosysbiognosys.com
5. 5Biognosys (Switzerland)wikidata.org
6. 6Biognosys 推出扩展版蛋白质组学平台组合finanznachrichten.de
7. 7Indivumed与Biognosys宣布战略合作prnewswire.com